Exscientia claims world first as AI-created drug enters clin...

Drug discovery firm Exscientia has claimed a world first after announcing that the first precision engineered drug generated by artificial intelligence (AI) is entering clinical trials.

Despite benefits, blockchain adoption is slow in life scienc...

Oviva raises $21m for digital tool to help reverse diabetes

Swiss digital therapy specialist Oviva has raised $21 million in second-round financing to help expand the use of smartphone-based tools designed to help people with diabetes manage their c

Digital therapeutics and their impact on society

In the 20th century, research, technology and new novel treatments have enabled us to increase the average lifespan by 25 years, but our healthspan has not increased accordingly.

NICE backs Medtronic's AF monitor in post-stroke patients

England’s NHS could prevent hundreds of strokes of unknown cause with a new implantable monitor that transmits data to doctors remotely, which is recommended for funding following draft gui